John Puisis
Advertisement
John Puisis is a consultant with Spencer Stuart, an investment advisor specializing in biotech and pharmaceutical companies, based in Chicago.
Articles by John Puisis
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
2
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
3
Pharma Funding Roundup: Excalipoint Therapeutics Completes $68.7 Million Seed Finance Round, Crossbow Therapeutics Raises $77 Million in Series B Financing
4
How Are Automation and AI Impacting the Timeline From Prescription to Starting Treatment?
5